Clinical Trial Detail

NCT ID NCT02915523
Title Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Syndax Pharmaceuticals
Indications

peritoneum cancer

ovary epithelial cancer

fallopian tube cancer

Therapies

Avelumab

Avelumab + Entinostat

Age Groups: senior adult

No variant requirements are available.